Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2009.05.020PMID 19541356PMCID PMC3056058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.

  2008cited by this paper
• Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.

  2008cited by this paper
• The prevalence of atopic triad in children with physician-confirmed atopic dermatitis.

  2008cited by this paper
• Antimicrobial peptides and the skin immune defense system.

  2008cited by this paper
• Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: implications for allergic respiratory disease and prognosis.

  2008cited by this paper
• Filaggrin in atopic dermatitis.

  2008cited by this paper
• Severe eczema vaccinatum in a household contact of a smallpox vaccinee.

  2008cited by this paper
• Risk factors of atopic dermatitis patients for eczema herpeticum.

  2007cited by this paper
• Cytokine modulation of atopic dermatitis filaggrin skin expression.

  2007cited by this paper
• Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus.

  2007cited by this paper
• Cathelicidin deficiency predisposes to eczema herpeticum.

  2006cited by this paper
• Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

  2006cited by this paper
• Eczema herpeticatum

  2006cited by this paper
• Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

  2006cited by this paper
• Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

  2006cited by this paper
• Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey.

  2005cited by this paper
• Human Cathelicidin (LL-37), a Multifunctional Peptide, is Expressed by Ocular Surface Epithelia and has Potent Antibacterial and Antiviral Activity

  2005cited by this paper
• Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

  2004cited by this paper
• Contrasting disease patterns in psoriasis and atopic dermatitis

  2004cited by this paper
• Eczema herpeticatum

  2004cited by this paper
• Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.

  2003cited by this paper
• Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.

  2003cited by this paper
• Consensus conference on pediatric atopic dermatitis.

  2003cited by this paper
• The evaluation and management of food allergy in atopic dermatitis.

  2003cited by this paper
• Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

  2002cited by this paper
• Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis.

  2002cited by this paper
• Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

  2001cited by this paper
• The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.

  2001cited by this paper
• The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

  2001cited by this paper
• A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.

  2000cited by this paper
• Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children.

  2000cited by this paper
• Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.

  1999cited by this paper
• Prevalence of IgE-Mediated Food Allergy Among Children With Atopic Dermatitis

  1998cited by this paper
• Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop®)

  1998cited by this paper
• IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team.

  1996cited by this paper
• Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

  1994cited by this paper
• The use of Phadiatop® in mass‐screening programmes of inhalant allergies: advantages and limitations

  1990cited by this paper
• Grading of the severity of atopic dermatitis.

  1989cited by this paper
• Increasing incidence of eczema herpeticum: analysis of seventy-five cases.

  1988cited by this paper

• Skin Infections in Atopic Dermatitis: Treatment Challenges

  2025cites this paper
• The real‐world, long‐term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study

  2025cites this paper
• IL-4 impairs the formation of skin-resident memory CD8+ T cells

  2025cites this paper
• Skin and systemic infections in children with atopic dermatitis: review of the current evidence

  2025cites this paper
• Infections in Patients with Atopic Dermatitis and the Influence of Treatment

  2025cites this paper
• The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults

  2025cites this paper
• Skin infections in atopic dermatitis: clinic, treatment. A review

  2024cites this paper
• Comparative efficacy of combined antihistamine and montelukast therapy in adult patients with atopic dermatitis

  2024cites this paper
• Viral infections in atopic dermatitis.

  2024cites this paper
• The skin microbiome in pediatric atopic dermatitis and food allergy

  2024cites this paper
• Eczema Herpeticum: Clinical Insights and Pathogenesis Hypotheses on Basolateral Adhesion Proteins

  2024influential citation
• Atopic Dermatitis Complicated by Recurrent Eczema Herpeticum Is Characterized by Multiple, Concurrent Epidermal Inflammatory Endotypes

  2024cites this paper
• Challenge in Diagnosis of Eczema Herpeticum in Rural Area in East Nusa Tenggara: a Case Report

  2024cites this paper
• Impaired endocytosis and accumulation in early endosomal compartments defines herpes simplex virus–mediated disruption of the nonclassical MHC class I–related molecule MR1

  2024cites this paper
• Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.

  2024cites this paper
• Eczema Herpeticum Complicating Atopic Dermatitis: A Rare Presentation

  2024cites this paper
• Atopic dermatitis complicated by recurrent eczema herpeticum is characterized by multiple, concurrent epidermal inflammatory endotypes

  2023cites this paper
• Recent insights into comorbidities in atopic dermatitis

  2023cites this paper
• S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection

  2023cites this paper
• Clinical Evidence: External Factors

  2023cites this paper
• Human skin bacterial microbiota homeostasis: A delicate balance between health and disease

  2023cites this paper
• Increased Risk of Renal Malignancy in Patients with Moderate to Severe Atopic Dermatitis

  2023cites this paper
• Hohe Rezidivrate des Eczema herpeticatum bei mittelschwerer bis schwerer atopischer Dermatitis – eine TREATgermany Registeranalyse

  2023cites this paper
• Clinical case of atopic dermatitis complicated by Kaposi’s varicelliform eruption

  2023cites this paper
• JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes

  2023cites this paper
• Vitamin D and the skin: an immunologic and therapeutic update

  2023cites this paper
• Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity from the ADRN Registry.

  2023cites this paper
• Phenotypes of atopic dermatitis.

  2023cites this paper
• History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis

  2023cites this paper
• Dupilumab strengthens HSV-1 specific immune responses in atopic dermatitis.

  2023cites this paper
• Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis

  2023cites this paper
• High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis –TREATgermany registry analysis

  2023influential citation
• Bacterial infections are common among eczema herpeticum inpatients in a cross‐sectional analysis of the 2016 Kids' Inpatient Database

  2023cites this paper
• Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment.

  2023cites this paper
• Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus

  2022cites this paper
• Management of Atopic Dermatitis with Individualised Homoeopathic Treatment

  2022cites this paper
• Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials

  2022cites this paper
• Safety outcomes for topical corticosteroid use in eczema herpeticum: a single-centre retrospective cohort study.

  2022cites this paper
• Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.

  2022cites this paper
• The Genetics of Eczema Herpeticum

  2022cites this paper
• Sharing is caring? Skin microbiome insights into staphylococci in atopic dermatitis patients and caregivers.

  2022cites this paper
• Knowledge and phobias about the use of topical corticosteroids among the Saudi population: A cross-sectional study

  2022cites this paper
• A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

  2022cites this paper
• Genetic/Environmental Contributions and Immune Dysregulation in Children with Atopic Dermatitis

  2022cites this paper
• Herpesvirus, serious and opportunistic infections associated with atopic dermatitis

  2022cites this paper
• Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics

  2022cites this paper
• Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections.

  2022cites this paper
• Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients

  2022cites this paper
• Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in patients with atopic dermatitis

  2022cites this paper
• A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

  2022cites this paper
• Atopic Dermatitis and Allergic Contact Dermatitis

  2022cites this paper
• An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

  2022cites this paper
• Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management

  2021cites this paper
• Herpes simplex virus 1 proteins can induce skin inflammation in an atopic dermatitis‐like mouse model

  2021cites this paper
• Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum

  2021cites this paper
• Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

  2021cites this paper
• Retrospective analysis of adverse events with dupilumab reported to the United States Food and Drug Administration.

  2021cites this paper
• Risk of systemic infections requiring hospitalization in children with atopic dermatitis: a Danish retrospective nationwide cohort study *

  2021cites this paper
• Eczema herpeticum in atopic dermatitis

  2021cites this paper
• The link between atopic dermatitis and asthma- immunological imbalance and beyond

  2021cites this paper
• Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease.

  2021cites this paper
• Atopic Eczema: Pathophysiological Findings as the Beginning of a New Era of Therapeutic Options.

  2021cites this paper
• Exogenous factors in the pathogenesis of atopic dermatitis: Irritants and cutaneous infections

  2021cites this paper
• Characterization of Human Keratinocyte Cell Lines for Barrier Studies

  2021cites this paper
• The effects of topical steroid fears and concerns on patients with eczema: first TOPICOP© scale-based study in Saudi Arabia

  2021cites this paper
• Combination of FLG mutations and SNP of TSLP (rs1898671) influence on atopic dermatitis occurrence

  2021cites this paper
• Multiple Choice-Fragen : Atopisches Ekzem VNR : 2760602021198960002 ( eine Antwort ist richtig ) 1

  2021cites this paper
• Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?

  2021cites this paper
• How far is vitamin D implicated in cutaneous infections.

  2021cites this paper
• Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans

  2021cites this paper
• Role of Infection and Microbial Factors

  2021cites this paper
• Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

  2021cites this paper
• Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-control study.

  2021cites this paper
• Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population‐based cohort study *

  2021cites this paper
• Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.

  2021cites this paper
• Atopic dermatitis

  2020cites this paper
• Eczema herpeticum emerging during atopic dermatitis in infancy.

  2020cites this paper
• Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study.

  2020cites this paper
• The clinical significance of fungi in atopic dermatitis

  2020cites this paper
• Nasal Colonization by Staphylococci and Severity of Atopic Dermatitis

  2020cites this paper
• 아토피피부염의 표현형과 내재형

  2020cites this paper
• Phenotypes and endotypes of atopic dermatitis: Clinical implications

  2020cites this paper
• Skin Tape Sampling Technique Identifies Proinflammatory Cytokines in Atopic Dermatitis Skin.

  2020cites this paper
• Interferon Kappa Is Important for Keratinocyte Host Defense against Herpes Simplex Virus-1

  2020cites this paper
• Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis.

  2020cites this paper
• IgE reactivity against herpes simplex virus 1 in patients with atopic dermatitis complicated by eczema herpeticum

  2020cites this paper
• Pathophysiology, Diagnosis, and Management of Infections in Atopic Dermatitis

  2019cites this paper
• Comorbidities and the impact of atopic dermatitis.

  2019cites this paper
• Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

  2019cites this paper
• More than skin deep: the systemic nature of atopic dermatitis

  2019cites this paper
• Korean red ginseng water extract alleviates atopic dermatitis-like inflammatory responses by negative regulation of mitogen-activated protein kinase signaling pathway in vivo.

  2019cites this paper
• SnapshotDx Quiz: December 2019.

  2019cites this paper
• Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).

  2019cites this paper
• Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients

  2019cites this paper
• Frequency and Clinical Features Associated With Eczema Herpeticum in Hospitalized Children With Presumed Atopic Dermatitis Skin Infection

  2019cites this paper
• Atopische Dermatitis und internistische Komorbiditäten

  2019cites this paper
• The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype

  2019cites this paper
• Replicated methylation changes associated with eczema herpeticum and allergic response

  2019cites this paper
• Die atopische Dermatitis als Vorbote

  2019cites this paper
• The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

  2019cites this paper